Valuation Eurofins Scientific SE

Equities

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-03-06 am EST			5-day change	1st Jan Change
64.58 ^EUR	-1.64%		-5.25%	+3.49%

Mar. 05	Moody's Affirms Eurofins Scientific's Ratings, Outlook on Solid Operating Performance in FY25	MT
Feb. 17	CIC Corporate Upgrades Eurofins Scientific to Buy Rating, Boosts PT	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	20,893	12,900	11,336	9,273	11,036	11,386	-	-
Change	-	-38.26%	-12.13%	-18.2%	19.02%	3.16%	-	-
Enterprise Value (EV) ¹	23,132	15,739	14,041	12,269	11,036	14,830	14,365	14,055
Change	-	-31.96%	-10.79%	-12.62%	-10.05%	34.38%	-3.14%	-2.16%
P/E ratio	27.8x	22.2x	45.4x	26.9x	28x	21.1x	16.8x	14.2x
PBR	4.49x	2.7x	2.24x	1.73x	-	2.39x	2.16x	2x
PEG	-	-1x	-0.8x	0.7x	1.3x	0.6x	0.7x	0.8x
Capitalization / Revenue	3.11x	1.92x	1.74x	1.33x	1.51x	1.49x	1.39x	1.3x
EV / Revenue	3.44x	2.34x	2.16x	1.77x	1.51x	1.94x	1.75x	1.61x
EV / EBITDA	12.2x	10.4x	10.3x	7.91x	6.73x	8.48x	7.44x	6.66x
EV / EBIT	15.7x	15.2x	16.7x	12.1x	10.2x	13.1x	11.3x	9.9x
EV / FCF	22.8x	23.2x	29.6x	15.3x	-	21.4x	16.8x	15.3x
FCF Yield	4.39%	4.3%	3.38%	6.53%	-	4.67%	5.95%	6.54%
Dividend per Share ²	1	1	0.5	0.5	-	0.7543	0.8449	0.935
Rate of return	0.92%	1.49%	0.85%	1.01%	-	1.17%	1.31%	1.45%
EPS ²	3.91	3.02	1.3	1.83	2.23	3.058	3.843	4.558
Distribution rate	25.6%	33.1%	38.5%	27.3%	-	24.7%	22%	20.5%
Net sales ¹	6,718	6,712	6,515	6,951	7,296	7,642	8,197	8,745
EBITDA ¹	1,902	1,513	1,364	1,552	1,641	1,750	1,930	2,112
EBIT ¹	1,473	1,037	842	1,017	1,079	1,136	1,270	1,420
Net income ¹	783	606	310	406	475	572.7	728.3	854.5
Net Debt ¹	2,239	2,839	2,705	2,996	-	3,445	2,980	2,669
Reference price ²	108.80	67.06	58.98	49.31	62.40	64.58	64.58	64.58
Nbr of stocks (in thousands)	192,035	192,365	192,194	188,049	176,864	176,301	-	-
Announcement Date	2/22/22	3/1/23	2/27/24	1/30/25	1/29/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EUROFINS SCIENTIFIC SE	21.12x	1.94x	8.48x	1.17%	13.21B
LONZA GROUP AG	35.29x	5.14x	17.22x	0.97%	45.49B
BEONE MEDICINES AG	54.35x	4.68x	31.54x	-.--%	33.41B
CELLTRION, INC.	56.43x	11.55x	32.31x	0.34%	31.32B
IQVIA HOLDINGS INC.	21.15x	2.46x	10.59x	-.--%	29.29B
REVOLUTION MEDICINES, INC.	-12.85x	334.46x	-10.88x	-.--%	19.5B
ASCENDIS PHARMA A/S	45.29x	8.66x	27.2x	-.--%	14.77B
MEDPACE HOLDINGS, INC.	27.52x	4.39x	19.99x	-.--%	13.36B
IONIS PHARMACEUTICALS, INC.	-18.31x	14.28x	-19.9x	-.--%	12.23B
Average	25.56x	43.06x	12.95x	0.28%	23.62B
Weighted average by Cap.	31.28x	36.38x	16.39x	0.33%